St. James Investment Company’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-97,746
Closed -$9.72M 31
2024
Q4
$9.72M Sell
97,746
-122,717
-56% -$12.7M 1.68% 21
2024
Q3
$25M Sell
220,463
-13,575
-6% -$1.61M 4.23% 10
2024
Q2
$29M Sell
234,038
-14,423
-6% -$1.86M 5.07% 8
2024
Q1
$32.8M Sell
248,461
-28,765
-10% -$3.55M 5.35% 7
2023
Q4
$30.2M Sell
277,226
-21,009
-7% -$2.18M 4.9% 9
2023
Q3
$30.7M Sell
298,235
-16,770
-5% -$1.81M 4.68% 9
2023
Q2
$36.3M Sell
315,005
-13,276
-4% -$1.51M 5.28% 7
2023
Q1
$34.9M Sell
328,281
-9,854
-3% -$1.06M 5.17% 8
2022
Q4
$37.5M Sell
338,135
-8,513
-2% -$870K 5.66% 6
2022
Q3
$29.9M Sell
346,648
-555
-0.2% -$49.5K 4.8% 7
2022
Q2
$31.7M Buy
347,203
+1,434
+0.4% +$127K 5.17% 6
2022
Q1
$28.4M Buy
+345,769
New +$27.3M 4.33% 10

Other funds holding MRK

St. James Investment Company's MRK Position: Q1 2025 in Review

St. James Investment Company sold out of Merck (MRK) in Q1 2025, closing a stake of 97,746 shares — an estimated $9.72M sold.

St. James Investment Company first reported a position in MRK in Q1 2022 and held it in 12 quarters. The position peaked at $37.5M in Q4 2022. 3,448 funds tracked by Wall St. Rank hold MRK as of Q1 2025.

  • St. James Investment Company reported no remaining Merck position as of Q1 2025 after selling out during the quarter.
  • St. James Investment Company sold 97,746 Merck shares in Q1 2025, an estimated $9.72M.
  • St. James Investment Company first reported a position in Merck in Q1 2022 and held it in 12 quarters.
  • St. James Investment Company's Merck position peaked at $37.5M in Q4 2022.
  • 3,448 funds tracked by Wall St. Rank held Merck as of Q1 2025.

Based on St. James Investment Company's 13F filing for Q1 2025, filed 28 Apr 2025.